Name: Joe Rogan Experience #2376 - Brigham Buhler
Uploaded: 2025-09-09T17:00:25.000Z
Description: Watch the stand-up comedy video 'Joe Rogan Experience #2376 - Brigham Buhler' from PowerfulJRE on Comedy Buff. Published 2025-09-09. Transcript available.

Watch the stand-up comedy video 'Joe Rogan Experience #2376 - Brigham Buhler' from PowerfulJRE on Comedy Buff. Published 2025-09-09. Transcript available.

Joe Rogan Experience #2376 - Brigham Buhler

Joe Rogan podcast, check it out.
The Joe Rogan experience.
Train by day, Joe Rogan podcast by night, all day.
What up?
What up, dawg?
How are you?
We're back.
We're back again.
How many text messages have we been exchanging back and forth where we're like,
what the
fuck?
Oh, it's nuts.
It goes so deep.
It goes so deep.
This is to me, this is one of the most exciting moments in terms of like
politics, in terms
of like who's in control, like having RFK Jr. at the helm of the HHS and having
him like
really pushing to get peptides through, really pushing to stop all this
bullshit that's been
going on and seeing all these fucking roaches coming running out when the
lights come on.
Yeah.
It's been crazy.
It's definitely been crazy.
And for anyone who doesn't know my background, because if they haven't heard
our previous podcast,
you know, I started out as a drug rep for Eli Lilly, and I did that for three
years.
So I saw behind the curtain.
This was right out of college.
And then I was a med device rep.
And then I owned labs, blood labs, toxicology labs, pharmacogenetic labs.
I tried to go educate clinicians on all this preventative care stuff within the
insurance
framework, within the system.
And I was, I've been blowing the, you and I did, I think the first one four
years ago,
where I was trying to blow the whistle on, there is a lot of corruption, collusion,
and
corporate capture throughout every one of these organizations, top to bottom,
every alphabet
organization, whether we're talking the EPA, the CDC, the NIH, the FDA.
Did you see the guy from the CDC that just resigned?
Oh, my God.
The guy who, he has like literally a pentagram dog collar thing on his chest.
Do you know this guy?
Oh, I know what you're talking about.
This fucking freak who's upset that they're not giving babies hepatitis B shots.
I saw, he literally in an interview yesterday said his biggest concern is that
they're going
to get rid of hepatitis B shots.
Children aren't having sex or shooting up drugs.
Why do they need a hep B shot?
Because they're paying.
Because hep B shots are paying.
Yeah.
They're paying.
Well, and that's the.
It's money.
The problem is, as you like systematically walk through these systems in the
history of
each one of these organizations, I can show you time and time again.
And I went from, you know, coming on this podcast and trying to educate people
on the importance
of taking themselves out of that system, doing blood work, getting proactive
and predictive,
preventing chronic disease.
Don't put your hands in the fate of these broken systems.
And that led to getting to meet RFK and being a part of the Maha movement, testifying
in front
of the Senate, and then I've testified at the state level.
And Joe, the fucking level of fuckery and shady shit that I've seen now behind
the scenes
getting line of sight into the government side, because I didn't, I was on the
outside in
the periphery, somewhat aware of the government stuff.
But now having got behind the curtain, dude, it runs so much deeper and it's so
much darker
and it's so much more controlled than I ever realized.
Well, it's all money, man.
And there's so much money.
I mean, it has to be one of the biggest industries in the country, right?
Oh, I think HHS and even HHS, which all falls under Secretary Kennedy now, I
think it's between
70 and 80,000 people, right?
And so when people are asking, why aren't we moving faster?
Why aren't we doing this?
Why aren't we doing that?
It's like, you're trying to move the Titanic.
There's all these divisions within HHS, the CDC, the NIH, the FDA, and it's
whack-a-mole.
And every day, a new fire pops up.
And every day, you've got industry lobbying, politicking, and moving chess
pieces to obstruct,
delay, deny, depose, and prevent any sort of change.
And you've got legacy employees.
There is literally a memo at the NIH that's being circulated around about how
to subvert
and ignore President Trump and Secretary Kennedy's mandates, which isn't
President Trump and
Secretary Kennedy.
It's the American people's voice.
The American people voted for change.
We're over the corruption.
We're over the collusion.
We're over the corporate capture.
And for most people that I know, this was one of the biggest factors in this
administration,
like voting in Trump.
One of the biggest things was getting Kennedy in there.
Same.
Yeah.
I believe that the Maha Moms and this health care movement and the frustration
with the
broken health care system was a deciding factor in Trump winning this election.
And my fear is, if we don't keep the pressure up at these midterms, it doesn't
matter Republican
or Democrats.
Historically, both sides have been corrupted.
And both sides have made catastrophic mistakes.
And if we walk through like each one of these organizations, like back to the,
even the FDA.
Okay.
So most recently, I'm in Europe and I've got eyes and ears everywhere.
Or you tell me where the best place to start is because I want to, there's so
much ground
to cover.
Okay.
So Secretary Kennedy set up a meeting for me with the FDA back in January.
And he said, I want you to come with an open mind, open heart.
They're going to do the same.
And I want you to just sit down and lay out for these folks what you've seen,
what you've
experienced and help them understand what compounders, telemedicine companies,
stem cell
companies, regenerative medicine practices, cash pay practices across the
country are experiencing
because of the FDA's choices and decisions made in a vacuum.
And so I went to this meeting, flew to DC, sat down with all these folks.
They're taking notes.
They all seemed really friendly.
There was probably eight or nine people in the room and I left there.
And a day later, and everyone's like, how do you think it went?
I said, they seem very receptive.
Like everyone was nice.
Everyone smiled and everyone was just seemed friendly.
And to God, I get a call from a person at the FDA and they say, I want you to
know they're
going to smile.
Fuck you.
And I said, what?
And this person said, they're going to smile.
Fuck you.
And I go, what do you mean?
They're going to smile to your face and they're going to ramrod all the things
that you went
in to talk to them about.
So like one of the things that I wanted to talk to them about was the GLP ones.
Forget whether good or bad.
Let's just shelf that for the moment.
GLP ones have their origination at the National Institute for Health.
Let's explain to people that's Ozempic, Wagovi.
Yes, correct.
Those weight loss peptides.
All these blockbuster weight loss peptides.
But it's bigger than them being a weight loss peptide.
They fall under the category of peptides.
And it's a slippery slope because if we allow the pharmaceutical industry to
capture peptides,
it will shut down all future innovation of peptides for compounding pharmacies,
for telemedicine,
for any of these things.
Unless they have patents on it.
Correct.
And you and I talked about this the last podcast and I was spot on.
All the things I was telling you, I have now confirmed having gone to meetings
with the
FDA.
I sat in that meeting and I said, so what happened is Eli Lilly is now one of
the largest
makers of this weight loss peptide.
It's essentially Novo Nordisk and Eli Lilly.
They have lobbied hard with the FDA to say, we can meet the needs of the
American people.
There is no reason why anybody should be compounding any of these peptides.
They're dangerous.
You guys don't inspect compounding pharmacies.
There's no FDA oversight.
These products are made in garages and there's no FDA ingredients in them.
They're not the same product.
X, Y, Z.
Just go down the list of all the narratives that they're spinning to the FDA.
And when the FDA is only hearing one side of the story and 60% of their funding
comes
from industry, what you will see is time and time again, they side with
industry.
So, the FDA defaulted right before to their generic answer, right before
Secretary Kennedy
and Donald Trump took control.
They expired the exemption that was allowing compounding pharmacies to make
cost-effective
alternatives that patients could utilize.
And this is crucial.
The reason that you're seeing side effects, the reason you're seeing this
cascade effect
of issues is because they are not treating patients with the most efficacious
dose for that patient.
They're treating patients with the dosage that reimburses the highest reimbursement
rate
on the insurance formulary.
And I can prove this.
They are overdosing people under, like, literally, they're not taking the time
to do the consult
to educate the patient on diet, lifestyle, and nutrition.
There is zero doubt that GLP-1s are overutilized in America.
There's zero doubt that they should not be a frontline defense.
There is zero doubt that they don't come with some sort of risk factors.
But most of those risk factors are found in higher dosages.
So, why would you start a patient on a higher dosage?
Why would you rapidly titrate them up to a higher dosage where you're causing
catastrophic
muscle loss?
It's because it reimburses more.
It's not because it's what's better for the patient.
It's because it's what's better for Wall Street.
And then their answer is, compounding pharmacies, we titrate at a lower dosage.
We're unique to the patient.
So, what we try to do is start you at a micro-dose.
And then, also, what we do is compound it and add other peptides.
So, like, one example of, they're literally working to patent a combination of
a GLP-1 and
IGF-LR3.
We've been making that for five years.
Like, four years.
Say that again.
So, GLP-1.
What is an IGF?
The weight loss.
An IGF, insulin growth factor, LR3.
Time-released insulin growth factor.
And the reason being, IGF preserves lean muscle mass.
IGF preserves bone mineral density.
IGF helps reduce visceral fat.
IGF has a cascade of benefits that allow us to micro-dose a GLP-1 at a much
lower dosage
where you don't get the muscle wasting.
And so, this compound in trials right now is showing 20% body fat loss relative
to the GLP-1s.
But all of it's body fat.
Almost all of it is fat.
You're not losing the muscle.
And compounders are already making this stuff, right?
And so, where I'm going with this is Lilly lobbies the FDA in Novo Nordisk.
And they say these drugs are dangerous.
Let's look into that.
Step one.
Eli Lilly and Novo Nordisk both have warning letters from the FDA for their
manufacturing facilities.
Novo Nordisk was cited as having cat hair and pest activity.
I don't know if it's rats, if it's roaches, in their sterile rooms.
This is the FDA's own inspection.
Eli Lilly has been cited time and time again for his egregious actions,
destroying records,
hiding clinical data, a barefoot woman in their sterile room.
The FDA uncovered all of this through whistleblowers.
Furthermore, there's over 2,000 major pharmaceutical manufacturing facilities
that have not been investigated in five or more fucking years.
And so, my message to the FDA was,
one, you're wrong.
You've inspected me three times in 18 months.
Two, Eli Lilly and Novo Nordisk are not making a safer product.
They're not at a higher level of manufacturing specs.
You guys look at them less often than you do compounders.
And they don't make dosages unique to patients.
So, we're titrating dosages down, allowing patients to optimize the benefits,
minimize the side effects.
Not a one-size-fits-all approach.
And then, last but not least, it's cash pay.
We aren't billing insurance carriers.
We aren't billing Medicare, Medicaid.
And we're not charging $1,300 a month average wholesale price.
We're able to ship these products for a couple hundred bucks to your doorstep
with a nutritional consult.
And so, it's a better mousetrap.
And what you'll see time and time again is if industry's getting beat,
if big pharma's getting beat, they just change the rules to the game.
And so, where this is going, though, is so much bigger and grander, Joe.
So, I asked the FDA, what 